Back

Using EEG to measure the neural effects of oxytocin administration: A meta-analysis and systematic review

Deilhaug, E.; Moerkerke, M.; Sartorius, A. I.; Kang, H.; Kildal, E. S.; Kjersti, W. M.; Elvsashagen, T.; Westlye, L. T.; Naerland, T.; Andreassen, O. A.; Quintana, D. S.

2025-08-26 psychiatry and clinical psychology
10.1101/2025.08.25.25334355
Show abstract

Electroencephalography (EEG) has emerged as a key method for investigating the neural mechanisms through which oxytocin influences cognition and behaviour. EEG is cost-effective, has excellent temporal precision, and may elucidate neural correlates of emotional and cognitive processes. EEG studies evaluating oxytocins electrophysiological effects have, however, yielded mixed results, which is likely driven by heterogeneity in EEG measures, study designs, dosages, and samples. To investigate the effect of oxytocin administration on EEG measures, we performed two multilevel random effects meta-analyses: The first meta-analysis synthesized studies investigating the effects of oxytocin administration on different neural correlates of social and cognitive processing; the second meta-analysis synthesized studies evaluating effects of oxytocin administration on exploratory, less task-specific neural activity measures, such as the modulation of microstates. Across both meta-analyses, we synthesized 161 effect sizes from 28 randomised controlled trials with a total of 1361 participants from different population groups. These multilevel meta-analyses yielded small effect sizes of oxytocin administration across different EEG measures reflecting social and cognitive processes (Hedges g = 0.14), and exploratory neural activity (Hedges g = 0.28) with significant heterogeneity estimates (p < 0.01 and p < 0.001, respectively). Moderator analyses revealed that the different EEG measurements of interest (e.g., event-related potentials) and the proportion of female participants were found to significantly moderate the effect of oxytocin on neural EEG activity. Altogether, these meta-analyses present tentative evidence for oxytocin administration modulating a wide range of neural activity. We observed substantial heterogeneity across studies - in terms of study designs, experimental paradigms and EEG measurements, and participant characteristics. More research is warranted to map out the context-specific effects of oxytocin administration on different neural markers, to better understand the neurobiological mechanisms of oxytocin.

Matching journals

1
Neuroscience & Biobehavioral Reviews
Elsevier BV · based on 19 published papers
#1
86× avg
2
Psychological Medicine
Cambridge University Press (CUP) · based on 52 published papers
Top 1%
23× avg
3
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
Elsevier BV · based on 27 published papers
Top 0.5%
56× avg
4
Translational Psychiatry
Springer Science and Business Media LLC · based on 94 published papers
Top 3%
10× avg
5
European Neuropsychopharmacology
Elsevier BV · based on 11 published papers
#1
79× avg
6
Biological Psychiatry
Elsevier BV · based on 36 published papers
Top 2%
19× avg
7
Journal of Affective Disorders
Elsevier BV · based on 72 published papers
Top 3%
11× avg
8
Scientific Reports
Springer Science and Business Media LLC · based on 701 published papers
Top 53%
2.9%
9
Molecular Psychiatry
Springer Science and Business Media LLC · based on 84 published papers
Top 3%
10× avg
10
Imaging Neuroscience
MIT Press · based on 18 published papers
Top 0.3%
50× avg
11
Frontiers in Psychiatry
Frontiers Media SA · based on 56 published papers
Top 4%
7.2× avg
12
PLOS ONE
Public Library of Science (PLoS) · based on 1737 published papers
Top 86%
2.3%
13
Human Brain Mapping
Wiley · based on 53 published papers
Top 4%
7.0× avg
14
NeuroImage: Clinical
Elsevier BV · based on 77 published papers
Top 5%
5.7× avg
15
NeuroImage
Elsevier BV · based on 36 published papers
Top 3%
9.4× avg
16
Brain and Behavior
Wiley · based on 19 published papers
Top 2%
13× avg
17
Clinical Neurophysiology
Elsevier BV · based on 19 published papers
Top 1%
18× avg
18
Progress in Neuro-Psychopharmacology and Biological Psychiatry
Elsevier BV · based on 10 published papers
Top 0.3%
30× avg
19
Brain Stimulation
Elsevier BV · based on 27 published papers
Top 2%
13× avg
20
eLife
eLife Sciences Publications, Ltd · based on 262 published papers
Top 23%
1.3%
21
Psychoneuroendocrinology
Elsevier BV · based on 12 published papers
Top 0.4%
32× avg
22
Frontiers in Neuroscience
Frontiers Media SA · based on 29 published papers
Top 3%
8.3× avg
23
Cerebral Cortex
Oxford University Press (OUP) · based on 15 published papers
Top 0.7%
27× avg
24
Brain Communications
Oxford University Press (OUP) · based on 79 published papers
Top 6%
4.1× avg
25
Biological Psychiatry Global Open Science
Elsevier BV · based on 23 published papers
Top 2%
14× avg
26
European Child & Adolescent Psychiatry
Springer Science and Business Media LLC · based on 14 published papers
Top 2%
14× avg
27
Psychiatry Research
Elsevier BV · based on 33 published papers
Top 4%
6.1× avg
28
Neuropsychopharmacology
Springer Science and Business Media LLC · based on 29 published papers
Top 3%
9.8× avg
29
Frontiers in Neurology
Frontiers Media SA · based on 74 published papers
Top 11%
0.8%
30
Schizophrenia
Springer Science and Business Media LLC · based on 13 published papers
Top 1%
11× avg